{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:58Z","timestamp":1744172938528,"version":"3.40.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T00:00:00Z","timestamp":1444176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11908-015-0505-6","type":"journal-article","created":{"date-parts":[[2015,10,7]],"date-time":"2015-10-07T08:50:11Z","timestamp":1444207811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients"],"prefix":"10.1007","volume":"17","author":[{"given":"Paul O.","family":"Gubbins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,7]]},"reference":[{"key":"505_CR1","unstructured":"Centers for Disease Control and Prevention 2013 \u201cDeaths: final data for 2013.\u201d http:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr64\/nvsr64_02.pdf accessed July 23, 2015."},{"key":"505_CR2","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.clinthera.2015.04.013","volume":"37","author":"H Park","year":"2015","unstructured":"Park H, Adeyemi AO, Rascati KL. Direct medical costs and utilization of health care services to treat pneumonia in the United States: an analysis of the 2007\u20132011 medical expenditure survey. Clin Ther. 2015;37:1466\u201376.","journal-title":"Clin Ther"},{"key":"505_CR3","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.vaccine.2014.02.008","volume":"32","author":"C Weil-Oliviera","year":"2014","unstructured":"Weil-Oliviera C, Gaillat J. Can the success of pneumococcal conjugate vaccines for the prevention of pneumococcal diseases in children be extrapolated to adults? Vaccine. 2014;32:2022\u20136.","journal-title":"Vaccine"},{"key":"505_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med. 2015;373:415\u201327.","journal-title":"N Engl J Med"},{"key":"505_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/cid\/ciu328","volume":"59","author":"AM Fry","year":"2014","unstructured":"Fry AM, Kim IK, Reed C, et al. Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults. Clin Infect Dis. 2014;59:406\u20139.","journal-title":"Clin Infect Dis"},{"key":"505_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/14787210.2015.981156","volume":"13","author":"A Campigotto","year":"2015","unstructured":"Campigotto A, Mubareka S. Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts. Expert Rev Anti Infect Ther. 2015;13:55\u201368.","journal-title":"Expert Rev. Anti Infect Ther"},{"key":"505_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/14760584.2015.957191","volume":"14","author":"I Christopolou","year":"2015","unstructured":"Christopolou I, Roose K, Iba\u00f1ez LI, Saelens X. Influenza vaccines to control influenza-associated bacterial infection: where do we stand? Expert Rev Vaccines. 2015;14:55\u201367.","journal-title":"Expert Rev Vaccines"},{"key":"505_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrmicro3231","volume":"12","author":"JA McCullers","year":"2014","unstructured":"McCullers JA. The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014;12:252\u201362.","journal-title":"Nat Rev Microbiol."},{"key":"505_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.chom.2014.06.005","volume":"16","author":"SJ Siegel","year":"2014","unstructured":"Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe. 2014;16:55\u201367.","journal-title":"Cell Host Microbe"},{"key":"505_CR10","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jamainternmed.2014.4344","volume":"174","author":"SB Smith","year":"2014","unstructured":"Smith SB, Ruhnke GW, Weiss CH, Waterer GW, Wunderink RG. Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011. JAMA Intern Med. 2014;174:1837\u20139.","journal-title":"JAMA Intern Med"},{"key":"505_CR11","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4187\/respcare.02788","volume":"59","author":"A Liapikou","year":"2014","unstructured":"Liapikou A, Polverino E, Cilloniz C, et al. Worldwide perspective of nursing home-acquired pneumonia compared to community-acquired pneumonia. Respir Care. 2014;59:1078\u201385.","journal-title":"Respir Care"},{"issue":"Suppl. 5","key":"505_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/1469-0691.12461","volume":"20","author":"JJC Drijkoningen","year":"2014","unstructured":"Drijkoningen JJC, Rohde GGU. Pneumococcal infection in adults: burden of disease. Clin Microbiol Infect. 2014;20 Suppl 5:45\u201351.","journal-title":"Clin Microbiol Infect"},{"key":"505_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijid.2015.05.003","volume":"37","author":"D Curcio","year":"2015","unstructured":"Curcio D, Cane' A, Isturiz R. Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence. Int J Infect Dis. 2015;37:30\u20135.","journal-title":"Int J Infect Dis"},{"key":"505_CR14","doi-asserted-by":"publisher","unstructured":"Shea KM, Edelsberg J, Weycker D, et al. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014. doi: 10.1093\/ofid\/ofu024. eCollection 2014","DOI":"10.1093\/ofid\/ofu024"},{"key":"505_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","volume":"372","author":"MJM Bonten","year":"2015","unstructured":"Bonten MJM, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372:1114\u201325.","journal-title":"N Engl J Med"},{"key":"505_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.4161\/hv.28962","volume":"10","author":"DM Weinberger","year":"2014","unstructured":"Weinberger DM, Shapiro ED. Pneumococcal conjugate vaccines for adults reasons for optimism and for caution. Hum Vaccine Immunother. 2014;10:1334\u20136.","journal-title":"Hum Vaccine Immunother"},{"key":"505_CR17","first-page":"822","volume":"63","author":"S Tomczyk","year":"2014","unstructured":"Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged\u2009\u2265\u200965 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014;63:822\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"505_CR18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.4161\/hv.28797","volume":"10","author":"DS Fedson","year":"2014","unstructured":"Fedson DS. Preventing non bacteremic pneumococcal pneumonia in older adults. Hum Vaccine Immunother. 2014;10:1322\u201330.","journal-title":"Hum Vaccine Immunother"},{"key":"505_CR19","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/cid\/ciu007","volume":"58","author":"KP Klugman","year":"2014","unstructured":"Klugman KP. A tale of 2 pneumococcal vaccines. Clin Infect Dis. 2014;58:925\u20137.","journal-title":"Clin Infect Dis"},{"key":"505_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijid.2014.12.035","volume":"33","author":"A Payeras","year":"2015","unstructured":"Payeras A, Villoslada A, Garau M, Salvador MN, Gallegos MC. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine. Int J Infect Dis. 2015;33:22\u20137.","journal-title":"Int J Infect Dis"},{"key":"505_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"MR Moore","year":"2015","unstructured":"Moore MR, Link-Gelles R, Schaffner W, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"505_CR22","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1093\/cid\/ciu002","volume":"58","author":"O Ochoa-Gondar","year":"2014","unstructured":"Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged \u226560 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis. 2014;58(7):909\u201317.","journal-title":"Clin Infect Dis"},{"key":"505_CR23","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/cid\/civ096","volume":"60","author":"M Leventer-Roberts","year":"2015","unstructured":"Leventer-Roberts M, Feldman BS, Brufman I, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive disease and hospital-treated pneumonia among people aged \u226565 years: a retrospective case-control study. Clin Infect Dis. 2015;60:1472\u201380.","journal-title":"Clin Infect Dis."},{"key":"505_CR24","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1016\/j.vaccine.2014.02.048","volume":"32","author":"TL Wiemken","year":"2014","unstructured":"Wiemken TL, Carrico RM, Klein SL, et al. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine. 2014;32:2198\u2013203.","journal-title":"Vaccine"},{"key":"505_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S2213-2600(14)70131-6","volume":"2","author":"MJ Mina","year":"2014","unstructured":"Mina MJ, Klugman KP. The role of influenza in the severity and transmission of respiratory bacterial disease. Lancet Respir Med. 2014;2:750\u201363.","journal-title":"Lancet Respir Med"},{"key":"505_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.jclinepi.2014.02.009","volume":"67","author":"M Darvishan","year":"2014","unstructured":"Darvishan M, Gefenaite G, Turner RM, et al. After adjusting for bias in meta-analysis seasonal vaccine remains effective in community dwelling elderly. J Clin Epidemiol. 2014;67:734\u201344.","journal-title":"J Clin Epidemiol"},{"key":"505_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.vaccine.2013.11.060","volume":"32","author":"HQ McLean","year":"2014","unstructured":"McLean HQ, Meece JK, Belongia EA. Influenza vaccination and risk of hospitalization among adults with laboratory confirmed influenza illness. Vaccine. 2014;32:453\u20137.","journal-title":"Vaccine"},{"key":"505_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1128\/CVI.00673-14","volume":"22","author":"JY Song","year":"2015","unstructured":"Song JY, Lee JS, Wie SH, et al. Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol. 2015;22:229\u201334.","journal-title":"Clin Vaccine Immunol"},{"key":"505_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jhm.2328","volume":"10","author":"C Li","year":"2015","unstructured":"Li C, Gubbins PO, Chen GJ. Prior pneumococcal vaccination and influenza vaccinations and in-hospitalization outcomes for community-acquired pneumonia in the elderly veterans. J Hosp Med. 2015;10:287\u201393.","journal-title":"J Hosp Med"},{"issue":"369(9568)","key":"505_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/S0140-6736(07)60564-9","volume":"7","author":"CG Grijalva","year":"2007","unstructured":"Grijalva CG, Nuorti JP, Arbogast PG, et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet. 2007;7(369(9568)):1179\u201386.","journal-title":"Lancet"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0505-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-015-0505-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0505-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-015-0505-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:04:36Z","timestamp":1744149876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-015-0505-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,7]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["505"],"URL":"https:\/\/doi.org\/10.1007\/s11908-015-0505-6","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"type":"print","value":"1523-3847"},{"type":"electronic","value":"1534-3146"}],"subject":[],"published":{"date-parts":[[2015,10,7]]},"assertion":[{"value":"7 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}